Prostaglandin levels in BL6 melanoma cells cultured in vitro: the effect of vitamin E succinate supplementationOTTINO, P; DUNCAN, J. R.Prostaglandins, leukotrienes and essential fatty acids. 1997, Vol 56, Num 6, pp 451-455, issn 0952-3278Article

Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibiter secretion by phorbol myristate acetateHART, D. A; SMITH, R.Cancer letters. 1987, Vol 35, Num 1, pp 27-38, issn 0304-3835Article

Bioactive alkaloids from Brunsvigia radulosaCAMPBELL, W. E; NAIR, J. J; GAMMON, D. W et al.Phytochemistry. 2000, Vol 53, Num 5, pp 587-591, issn 0031-9422Article

Adoptive immunotherapy of poorly immunogenetic tumors with in vitro sensitized cells generated by intratumoral administration of biological response modifiersMUKAI, S; KATO, H; KONDO, M et al.International journal of immunopharmacology. 1995, Vol 17, Num 12, pp 963-971, issn 0192-0561Article

Oleamide derivatives suppress the spontaneous metastasis by inhibiting connexin 26OHBA, Yusuke; KANAO, Yukiko; HANJUN ZHAO et al.International journal of cancer. 2007, Vol 121, Num 1, pp 47-54, issn 0020-7136, 8 p.Article

Induction of autocrine factor inhibiting cell motility from murine B16-BL6 melanoma cells by α-melanocyte stimulating hormoneMURATA, J; AYUKAWA, K; OGASAWARA, M et al.International journal of cancer. 1999, Vol 80, Num 6, pp 889-895, issn 0020-7136Article